Proceedings
(Aug 2019)
Metformin-Derived Hybrid Molecules for Glioblastoma Treatment
- Caroline Delehedde,
- Mathieu Chocry,
- Sophie Thétiot-Laurent,
- Françoise Garrouste,
- Marcel Culcasi,
- Hervé Kovacic,
- Sylvia Pietri
Affiliations
- Caroline Delehedde
- Aix Marseille Univ, CNRS, UMR 7273, ICR, SMBSO, 13013 Marseille, France
- Mathieu Chocry
- Aix Marseille Univ, CNRS, UMR 7273, ICR, SMBSO, 13013 Marseille, France
- Sophie Thétiot-Laurent
- Aix Marseille Univ, CNRS, UMR 7273, ICR, SMBSO, 13013 Marseille, France
- Françoise Garrouste
- Aix Marseille Univ, CNRS, UMR 7051, INP, 13005 Marseille, France
- Marcel Culcasi
- Aix Marseille Univ, CNRS, UMR 7273, ICR, SMBSO, 13013 Marseille, France
- Hervé Kovacic
- Aix Marseille Univ, CNRS, UMR 7051, INP, 13005 Marseille, France
- Sylvia Pietri
- Aix Marseille Univ, CNRS, UMR 7273, ICR, SMBSO, 13013 Marseille, France
- DOI
-
https://doi.org/10.3390/proceedings2019022083
- Journal volume & issue
-
Vol. 22,
no. 1
p.
83
Abstract
Read online
Glioblastoma is the most common cerebral tumor in adults. The median survival of glioblastoma patients is 12 months. [...]
Keywords
WeChat QR code
